The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: A surgical series from the Mayo Clinic

Diseases of the Esophagus

Volumn 23, Issue 3, 2010, Pages 232-239

  Schomas, David A ^a   Fernando Quevedo, J ^a   Donahue, James M ^a   Nichols III, Francis C ^a   Romero, Yvonne ^a   Miller, Robert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Celiac node metastasis; Chemoradiation therapy; Esophageal cancer; Esophagectomy; Stage IVA

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SURGICAL TECHNIQUE; ABDOMINAL TUMOR; CANCER STAGING; CARCINOMA; COHORT ANALYSIS; ESOPHAGUS TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL RATE;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77956794439     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00990.x     Document Type: Article

References (35)

1. Sons H U, Borchard F. Cancer of the distal esophagus and cardia: incidence, tumorous infiltration, and metastatic spread. Ann Surg 1986; 203: 188-95.
2. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg 1981; 194: 438-46.
3. Greene F L, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002.
4. Bolton J S, Fuhrman GM, RichardsonWS. Esophageal resection for cancer. Surg Clin North Am 1998; 78: 773-94.
5. Christie N A, Rice TW, DeCampMMet al. M1a/M1b esophageal carcinoma: clinical relevance. J Thorac Cardiovasc Surg 1999; 118: 900-7.
6. Eloubeidi M A, Wallace M B, Hoffman B J et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg 2001; 72: 212-9.
7. Hiele M, De Leyn P, Schurmans P et al. Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc 1997; 45: 381-6.
8. National Comprehensive Cancer Network [Internet]. National Comprehensive Cancer Network. c2007. NCCN Clinical practice guidelines in oncology. [Cited 20 Dec 2007.] Available from URL: http://www.nccn.org/professionals/physician_gls.
9. Rice T W, Blackstone E H, Rybicki L A et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 2003; 125: 1103-13.
10. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
11. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). (Published erratum appears in Jpn J Clin Oncol. 2005 Feb;35(2):108) Jpn J Clin Oncol 2004; 34: 615-9.
12. Forshaw M J, Gossage J A, Chrystal K et al. Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction. Eur J Surg Oncol 2006; 32: 1114-8. Epub 2006 Apr 18.
13. Clark GW, Peters J H, Ireland A P et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994; 58: 646-53.
14. Shim YM, Choi Y S, Kim K. Prognosis after surgical resection of M1a/M1b esophageal squamous cell carcinoma. J Korean Med Sci 2005; 20: 229-31.
15. Cooper J S, Guo M D, Herskovic A et al. Radiation Therapy Oncology Group. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623-7.
16. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
17. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
18. Tepper J E, Krasna M, Niedzwiecki D et al. Superiority of trimodality therapy to surgery alone in esophageal cancer: results of CALGB 9781 [abstract]. J Clin Oncol 2006; 24 (Suppl 18): 4012.
19. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
20. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. (Published erratum appears inNEngl JMed. 1999 Jul 29;341(5):384)NEngl J Med 1996; 335: 462-7.
21. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
22. Peto R, Pike M C, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977; 35: 1-39.
23. Cox D R. Statistical significance tests. Br J Clin Pharmacol 1982; 14: 325-31.
24. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-33.
25. Rudiger Siewert J, Feith M, Werner M, Stein H J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232: 353-61.
26. van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 1999; 15: 769-73.
27. Bedenne L, Michel P, Bouche O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-8.
28. Tepper J, Krasna M J, Niedzwiecki D et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-92.
29. Hagen J A, DeMeester S R, Peters J H, Chandrasoma P, DeMeester T R. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-30.
30. Korst R J, Rusch VW, Venkatraman E et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-9.
31. McKian K P, Miller R C, Cassivi S D, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus 2006; 19: 448-53.
32. Roder J D, Busch R, Stein H J, Fink U, Siewert J R. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-3.
33. Yano K, Okamura T, Yoshida Y, Ezaki T, Yasumoto K. The extent and number of metastatic lymph nodes limit the efficacy of lymphadenectomy in patients with oesophageal carcinoma. Surg Oncol 1994; 3: 187-92.
34. Skinner D B, Dowlatshahi K D, DeMeester T R. Potentially curable cancer of the esophagus. Cancer 1982; 50 (11 Suppl) 2571-5.
35. Macdonald J S. Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 2005; 90: 166-70.